Article
Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours.
Journal of neuro-oncology - 1 May 2015
Łastowska Maria, Jurkiewicz Elżbieta, Trubicka Joanna, Daszkiewicz Paweł, Drogosiewicz Monika, Malczyk Katarzyna, Grajkowska Wiesława, Matyja Ewa, Cukrowska Bożena, Pronicki Maciej, Perek-Polnik Marta, Perek Danuta, Dembowska-Bagińska Bożenna
Abstract excerpt
Recent studies revealed the biological heterogeneity of medulloblastoma, with the existence of at least four groups which are associated with several clinical and morphological features. We investigated for further correlations between molecular types, location of tumours, their contrast enhancement pattern and survival of patients. Altogether 76 tumours were analyzed and molecular subtypes were identified by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
